Equillium Stock Z Score
EQ Stock  USD 1.55 0.01 0.64% 
Equillium  Z Score 
Equillium Company Z Score Analysis
Equillium's ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 
 
 
 

Equillium Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Equillium is extremely important. It helps to project a fair market value of Equillium Stock properly, considering its historical fundamentals such as Z Score. Since Equillium's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Equillium's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Equillium's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a ZScore, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. ZScores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize zscores proved it to be successful as a predictor of corporate bankruptcy.
Competition 
According to the company's disclosures, Equillium has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Equillium Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Equillium's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Equillium could also be used in its relative valuation, which is a method of valuing Equillium by comparing valuation metrics of similar companies.Equillium is currently under evaluation in z score category among related companies.
Equillium Current Valuation Drivers
We derive many important indicators used in calculating different scores of Equillium from analyzing Equillium's financial statements. These drivers represent accounts that assess Equillium's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Equillium's important valuation drivers and their relationship over time.
2019  2020  2021  2022  2023  2024 (projected)  
Market Cap  58.7M  108.9M  108.6M  35.8M  25.1M  23.9M  
Enterprise Value  55.2M  93.2M  68.2M  (13.2M)  2.7M  2.6M 
Equillium Institutional Holders
Institutional Holdings refers to the ownership stake in Equillium that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Equillium's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in highprofile magazines, and presentations at investor conferences help move the stock higher, increasing Equillium's value.Shares  
Integrated Wealth Concepts Llc  20231231  40 K  
Northern Trust Corp  20231231  35.2 K  
Prudential Financial Inc  20240331  31.2 K  
Capital Cs Group, Llc  20231231  19 K  
Jane Street Group, Llc  20231231  12 K  
Tower Research Capital Llc  20231231  9.4 K  
Adar1 Capital Management Llc  20231231  6.5 K  
Simplex Trading, Llc  20240331  5.2 K  
Blackrock Inc  20231231  3.8 K  
Decheng Capital Llc  20231231  4.4 M  
Vanguard Group Inc  20240331  841.9 K 
Equillium Fundamentals
Return On Equity  0.48  
Return On Asset  0.14  
Profit Margin  (0.32) %  
Operating Margin  (0.26) %  
Current Valuation  22.71 M  
Shares Outstanding  35.25 M  
Shares Owned By Insiders  36.42 %  
Shares Owned By Institutions  20.00 %  
Number Of Shares Shorted  378.41 K  
Price To Earning  (6.70) X  
Price To Book  2.95 X  
Price To Sales  1.81 X  
Revenue  36.08 M  
Gross Profit  15.76 M  
EBITDA  (14.4 M)  
Net Income  (13.34 M)  
Cash And Equivalents  57.56 M  
Cash Per Share  1.68 X  
Total Debt  824 K  
Debt To Equity  0.29 %  
Current Ratio  3.98 X  
Book Value Per Share  0.60 X  
Cash Flow From Operations  (21.78 M)  
Short Ratio  2.99 X  
Earnings Per Share  (0.35) X  
Target Price  6.75  
Number Of Employees  44  
Beta  1.76  
Market Capitalization  55 M  
Total Asset  50.53 M  
Retained Earnings  (185.74 M)  
Working Capital  21.78 M  
Current Asset  60.04 M  
Current Liabilities  1.81 M  
Net Asset  50.53 M 
About Equillium Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Equillium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Equillium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Equillium based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient marketbeating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AIdriven system that provides multiple benefits to our users by leveraging cuttingedge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Equillium Piotroski F Score and Equillium Valuation analysis. To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Equillium Stock analysis
When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories  
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios  
Fundamental Analysis View fundamental data based on most recent published financial statements  
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios  
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments  
Content Syndication Quickly integrate customizable finance content to your own investment portal  
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon  
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities  
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings  
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital  
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and riskadjusted market performance  
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets  
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments 
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.35)  Revenue Per Share 1.085  Quarterly Revenue Growth 0.204  Return On Assets (0.14)  Return On Equity (0.48) 
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.